Acetone in drinking water does not modulate humoral immunity in mice as measured by the antibody, plaque-forming cell assay.
It has been reported that the repeated topical, nonoccluded application of acetone may modulate antibody production in mice, thus producing humoral immunosuppression. However, the evaporative loss expected following nonoccluded dermal application of acetone makes the systemic effect seem unlikely. This study was designed to investigate the immunotoxicity potential of acetone in mice following a more direct systemic route of dosing via drinking water for 28 days. CD-1 male mice consumed average daily acetone doses of 121, 621 or 1144 mg/kg/day. The antibody, plaque-forming cell (AFC) assay was performed to measure the T cell-dependent, anti-sheep red blood cell immunoglobulin M (IgM) response, and hematology and thymus weights were evaluated to provide additional insight into the potential effects to the immune system. Body weights, white blood cell (WBC), numbers, red blood cell (RBC) counts, and hemoglobin and hematocrit levels showed no treatment-related effects at any dose of acetone. Eosinophil percentages were variable but also showed no dose-related trends. Spleen and thymus weights were not statistically different from controls and there were no effects on spleen cellularity or AFC response as a result of acetone administration. The AFC responses ranged from 1088 to 1401 AFCs/10(6) splenocytes and were not statistically different from controls (1277 AFCs/10(6) cells). Mice treated with cyclophosphamide (20 mg/kg) on days 25 to 28 demonstrated a 94% reduction in AFC/10(6) cells. Thus, the direct systemic administration of acetone did not produce evidence for immunotoxicity in CD-1 mice and the no observed adverse effect level (NOAEL) in this study was determined to be 1144 mg/kg/day.
Woolhiser
Michael R
MR
Toxicology and Environmental Research and Consulting, The Dow Chemical Company, Midland, Michigan 48674, USA. MWoolhiser@dow.com
Houtman
Carrie E
CE
Waechter
John M
JM
D000096:Acetone / Q000633:toxicity*; D000818:Animals; D000917:Antibody Formation; D000921:Antibody-Producing Cells / Q000187:drug effects / Q000276:immunology; D006462:Hemolytic Plaque Technique; D007075:Immunoglobulin M / Q000276:immunology; D023441:Local Lymph Node Assay; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D012997:Solvents / Q000633:toxicity; D013154:Spleen / Q000187:drug effects / Q000276:immunology; D014867:Water
D007075:Immunoglobulin M; D012997:Solvents; D014867:Water; D000096:Acetone